Patent · US Active

Triazolo and tetrazolo pyrimidine derivatives as HNE inhibitors for treating COPD

US8569314B2 · kind B2 · utility

3Cited by

0References

6Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Franz Von Nussbaum · Mülheim an der Ruhr, DE
Dagmar Karthaus · Solingen, DE
Sonja Anlauf · Wuppertal, DE
Martina Delbeck · Essen, DE
Volkhart Min-Jian Li · Velbert, DE
Daniel Meibom · Leverkusen, DE
Klemens Lustig · Wuppertal, DE

Key dates

Filing date	Dec 29, 2009
Grant date	Oct 29, 2013
Priority date	—
Expiry date	Jan 22, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel heterocyclically fused diaryldihydropyrimidine derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.